Charles River Appoints Glenn Coleman As CFO And Kerry Dailey As Chief Legal Officer, Strengthens Leadership Team With New Appointments

Charles River Laboratories International, Inc. has announced two senior leadership appointments, naming Glenn G. Coleman as its next Chief Financial Officer and Kerry Dailey to the newly established role of Chief Legal Officer. These appointments are aimed at strengthening the company’s executive leadership team and supporting its long-term strategic objectives. 

Birgit Girshick, Corporate Executive Vice President, Chief Operating Officer and incoming Chief Executive Officer, commented, “We are very pleased to welcome Kerry Dailey and Glenn Coleman in two key executive roles, as we strengthen our leadership team to help us transform the Company to meet the current and future needs of our clients and the evolving industry landscape. Glenn is a seasoned financial executive in the healthcare sector who will bring to Charles River a wealth of strategic knowledge, a unique breadth of expertise in leading global Finance organisations, and strong operational experience. Kerry is an experienced leader who has been focused on advising multinational life science companies across complex regulatory environments. We are pleased that she will enable us to proactively manage our highly regulated, science-led organisation by combining our legal, compliance, communications, government relations, security, and ESG initiatives under one leader. We look forward to partnering with Glenn and Kerry as we work to advance our mission and position Charles River to enhance shareholder value by executing on our plans to drive long-term growth, greater efficiency, and operational excellence.”

Glenn Coleman will join the organisation as Corporate Executive Vice President and CFO on April 6. He will oversee the global finance organisation, including accounting, tax, treasury, investor relations, internal audit, risk management, procurement, and facilities. Coleman brings more than 30 years of financial and operational leadership experience, including senior roles in the healthcare sector. Most recently, he served as CFO and Chief Administrative Officer of a $1 billion healthcare services company. He previously held CFO roles at DENTSPLY SIRONA Inc. and Integra LifeSciences Holdings Corporation, where he also served as Chief Operating Officer. Earlier in his career, he held leadership positions at Curtiss-Wright Corporation and Alcatel-Lucent and began his professional journey at PricewaterhouseCoopers LLP. He will succeed Michael G. Knell, who has been serving as interim CFO since September 2025.

Glenn Coleman, incoming Corporate Executive Vice President and Chief Financial Officer, commented, “I am excited to join Charles River at a pivotal time in its history, and look forward to partnering with Jim, Birgit, and the entire team at Charles River to help lead the Company to its next chapter of growth. At Charles River, I will focus on execution to build upon the Company’s position as a life sciences industry leader while driving greater shareholder value through maximising our financial performance and maintaining a disciplined approach to capital deployment, including M&A, efficiently managing costs, and developing transformational strategies that drive positive change.”

Kerry Dailey will assume the role of Corporate Senior Vice President and Chief Legal Officer on March 30. In this newly created position, she will lead the company’s global legal function and oversee compliance, corporate communications, government relations, security, and ESG initiatives. She will also serve as a strategic advisor to the Board of Directors and executive leadership team. Dailey brings 25 years of legal experience advising multinational life sciences companies across complex regulatory environments.

Kerry Dailey, incoming Corporate Senior Vice President and Chief Legal Officer, commented, “I am looking forward to joining Charles River as it will be an incredible opportunity to contribute to a company that plays such a vital role in advancing scientific innovation and helping to create healthier lives. I look forward to collaborating across the organisation to help shape and accelerate our strategic imperatives by leveraging a consolidated stakeholder management approach to communications, government relations, compliance, and legal oversight to drive the Company’s continued growth and maintain our focus on leading with integrity in everything we do.”

Dailey joins Charles River from Alcon, Inc., where she held multiple senior legal leadership roles, most recently as Vice President, Legal and Assistant Corporate Secretary. Prior to Alcon, she served as Senior Counsel at Merial, a Sanofi company, and earlier practised corporate and securities law at leading firms including Latham & Watkins, Mayer Brown, and Freshfields. To support a smooth transition, Matthew L. Daniel, the company’s current General Counsel and Chief Compliance Officer, will assist through July 1 before stepping down after a 20-year tenure marked by significant contributions to M&A activity and the development of legal compliance.